Tuesday, September 13, 2011

Rasagiline

Selective MAO-B irreversible inhibitor.

Adv over Selegeline - OD dose, milder S/E, non-amphetamine metabolites

ADAGIO trial suggested neuroprotective at 1mg, but findings did not hold at 2mg/day.

No comments:

Post a Comment